| Programmable Molecular Tools
for Biology and Genome Editing |
| 11:00 AM EDT, April 15, 2025 |
REGISTER NOW |
|
| The intersection of biotechnology and artificial intelligence has ushered in a new era of possibilities in cellular biology and therapeutic intervention. From advanced gene editing techniques to AI-driven protein engineering, breakthrough developments in biotechnology are reshaping our current approach to biological systems and age-related diseases. The convergence of these fields has opened unprecedented opportunities for precision medicine, regenerative therapies, and the development of novel therapeutic strategies. Creative Biolabs is pleased to invite Dr. Omar Abudayyeh to explore these transformative technologies and their implications for the future of medicine and biotechnology, sharing insights into the latest developments and future direction of this rapidly evolving field. |
This webinar will discuss the following key points:
|
| • Novel Programmable Gene Editing and Replacement Technologies |
| • Applications of Cellular Perturbation Technologies for Aging and Regeneration |
| • AI Applications for Protein Evolution and Virtual Cells |
 Speaker |
 |
Omar Abudayyeh
Assistant Professor at Harvard Medical School
Investigator at Brigham and Women’s Hospital
Director of Gene Editing at MGB Gene and Cell Therapy Institute
|
|
| Omar Abudayyeh directs the Abudayyeh-Gootenberg lab developing gene editing and synthetic biology technologies through protein engineering and AI for therapeutics and aging research. A former McGovern Fellow at MIT with a Ph.D. from Harvard/MIT, he pioneered CRISPR innovations with dozens of patents and 35,000+ citations across 50+ publications in top journals. He co-founded Sherlock Biosciences, Proof Diagnostics, and Tome Biosciences, raising hundreds of millions for CRISPR-based applications. His accolades include Technology Review Innovators Under 35, Forbes 30 under 30, and Endpoints 20 under 40 Biotech Leaders. Abudayyeh graduated from MIT in 2012 with engineering degrees as a Henry Ford II and Goldwater Scholar, and studied medicine at Harvard Medical School. |
|
REGISTER NOW
Don’t miss this opportunity to learn about the latest developments in molecular tools and genome editing from one of the field’s leading innovators. All attendees who join the live webinar session will receive an official certificate of participation. Please feel free to arrange a call if you have any questions. |
| Meet Us at the Upcoming Events April 24, 2025 | NIH Spring Research Vendor Fair
May 7, 2025 | 23rd BioPharma Drug Discovery Nexus Conference
September 2025 | World Bispecific Summit
October 2025 | Exosome-Based Therapeutic Development Summit
November 2025 | World ADC San Diego
December 2025 | Antibody Engineering & Therapeutics (US) 2025
BOOK A MEETING
|
| As the leading service provider of gene therapy, Creative Biolabs has developed robust platforms covering a wide range of human diseases and is dedicated to advancing gene therapy development by one-stop services, including delivery vehicle development, gene editing, potency tests, safety and toxicology analysis, and I-O drug development. |
|
|
|
SUITE 203, 17 Ramsey Road, Shirley, NY 11967, United States of America
